Celularity regains Nasdaq compliance; reporting deficiency remains
Celularity said it regained Nasdaq minimum bid-price and market-value compliance, while a reporting deficiency remains unresolved.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.